Please login to the form below

Not currently logged in
Email:
Password:

patients

This page shows the latest patients news and features for those working in and with pharma, biotech and healthcare.

BMS’ new JAK inhibitor enters regulatory pathways

BMS’ new JAK inhibitor enters regulatory pathways

The two phase 3 studies in the POETYK-PSO programme evaluated the safety and efficacy of deucravacitinib compared to placebo and Otezla (apremilast) in patients with moderate to severe plaque psoriasis. ... The trials involving nearly 1, 700 patients

Latest news

More from news
Approximately 208 fully matching, plus 6,197 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 103 fully matching, plus 1,014 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 506 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 437 fully matching, plus 1,027 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...